Literature DB >> 6872199

The importance of the mitral apparatus in left ventricular function after correction of mitral regurgitation.

T E David, D E Uden, H D Strauss.   

Abstract

This study evaluates the possible role of the mitral apparatus in left ventricular function after correction of chronic mitral regurgitation. Seventeen patients underwent complete preoperative and early postoperative heart catheterization. Six patients underwent conventional mitral valve replacement (group 1), six mitral valve replacement with preservation of chordae tendineae and papillary muscles (group 2), and five mitral valvuloplasty (group 3). There was no statistically significant difference among the three groups for any hemodynamic parameter as compared before surgery by analysis of variance. After correction of mitral regurgitation the increase in cardiac index was similar for all three groups. Left ventricular end-diastolic volume did not decrease significantly in group 1 (p = NS), but it did in groups 2 and 3 (p less than .005 for both). Left ventricular end-systolic volume increased in group 1 (p less than .025) and decreased in groups 2 and 3 (p less than .01 and .005, respectively). Ejection fraction decreased in group 1 (p less than .005) and did not change in groups 2 or 3 (p = NS). Left ventricular end-diastolic pressure increased in group 1 (p less than .005) and decreased in groups 2 and 3 (p less than .01 for both). These findings suggest that continuity between mitral anulus and left ventricular wall through leaflets, chordae tendineae, and papillary muscles plays a role in left ventricular function after correction of the chronic mitral regurgitation.

Entities:  

Mesh:

Year:  1983        PMID: 6872199

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  26 in total

Review 1.  Surgical alternatives to transplantation and assist devices in the treatment of heart failure.

Authors:  J J DeRose; M C Oz
Journal:  Curr Cardiol Rep       Date:  2000-11       Impact factor: 2.931

Review 2.  Ischemic and functional mitral regurgitation in heart failure: natural history and treatment.

Authors:  Mina M Benjamin; Robert L Smith; Paul A Grayburn
Journal:  Curr Cardiol Rep       Date:  2014-08       Impact factor: 2.931

3.  Intraoperative color Doppler assessment of mitral and tricuspid valvuloplasty.

Authors:  G Maurer; L S Czer
Journal:  Int J Card Imaging       Date:  1989

4.  [Surgery in terminal mitral valve disease].

Authors:  M Bauer; M Pasic; R Hetzer
Journal:  Z Kardiol       Date:  2001-12

5.  [Mitral valve repair versus mitral valve replacement].

Authors:  J F Onnasch; F Schneider; M Mierzwa; F W Mohr
Journal:  Z Kardiol       Date:  2001-12

6.  Surgical application for a prolapse of the anterior mitral leaflet by replacing artificial chordae with polytetrafluoroethylene grafts.

Authors:  Yukihiro Tomita; Hisataka Yasui; Toshiro Iwai; Takahiro Nishida; Hideki Tatewaki; Shigeki Morita; Munetaka Masuda; Toru Yasutsune; Yosuke Nishimura
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

Review 7.  Mitral Regurgitation - A Multidisciplinary Challenge.

Authors:  Eduardo Alegria-Barrero; Olaf W Franzen
Journal:  Eur Cardiol       Date:  2014-07

Review 8.  Review of mitral valve insufficiency: repair or replacement.

Authors:  Athanasios Madesis; Kosmas Tsakiridis; Paul Zarogoulidis; Nikolaos Katsikogiannis; Nikolaos Machairiotis; Ioanna Kougioumtzi; George Kesisis; Theodora Tsiouda; Thomas Beleveslis; Alexander Koletas; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2014-03       Impact factor: 2.895

9.  The unsaddled annulus: biomechanical culprit in mitral valve prolapse?

Authors:  Morten O Jensen; Albert A Hagège; Yutaka Otsuji; Robert A Levine
Journal:  Circulation       Date:  2013-02-19       Impact factor: 29.690

10.  Left Ventricular Ejection Index as a Marker of Early Myocardial Dysfunction in Primary Mitral Regurgitation: Novel or Old in Disguise?

Authors:  Francesca N Delling
Journal:  Circ Cardiovasc Imaging       Date:  2015-09       Impact factor: 7.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.